Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Yarbrough

Thoracic Surgery (Cardiothoracic Vascular Surgery) West Columbia, SC Medical Doctor

NPI 1912193087 CMS profile 131890

2728 Sunset Blvd Ste 400, Ste 305, West Columbia, SC 29169

Open in the dashboard

General payments

$5,782

121 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Yarbrough of West Columbia, SC is reported in the CMS Open Payments database as having received $5,782 across 121 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 54th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,937 22
2024 General $846 17
2023 General $502 19
2022 General $779 20
2021 General $244 15
2020 General $187 8
2019 General $287 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Yarbrough
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to William Yarbrough were reported at $2,937. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year William Yarbrough Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $287 $886 $178–$3,167 $163
2020 $187 $341 $108–$1,605 $114
2021 $244 $453 $125–$1,886 $132
2022 $779 $695 $180–$2,566 $149
2023 $502 $745 $205–$2,662 $160
2024 $846 $799 $214–$2,967 $164
2025 $2,937 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $1,506 4 payments
  2. Abbott Laboratories $1,257 12 payments
  3. Medtronic, Inc. $1,020 23 payments
  4. Boehringer Ingelheim Pharmaceuticals, Inc. $439 22 payments
  5. Pfizer Inc. $254 19 payments
  6. Atricure, Inc. $201 8 payments
  7. Philips Electronics North America Corporation $186 4 payments
  8. LeMaitre Vascular, Inc. $136 3 payments
  9. Endologix, Inc. $122 2 payments
  10. Siemens Medical Solutions USA, Inc. $96 1 payment
  11. Other $565 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,418 112 payments
  2. Travel and Lodging $2,364 9 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $1,506 4 payments
  2. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $1,204 10 payments
  3. LINQ II $445 6 payments
  4. JARDIANCE $364 18 payments
  5. Micra $250 6 payments
  6. ELIQUIS $223 17 payments
  7. VYNDAQEL $181 14 payments
  8. AZURE XT DR MRI SURESCAN $154 3 payments
  9. AFX2 Bifurcated Endograft System $122 2 payments
  10. Ovation iX Iliac Stent Graft $122 2 payments
  11. Other $1,691 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

16

Median for Cardiac Surgery: 68

Drug cost

$206

Median for Cardiac Surgery: $445

Branded share of claims

100%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 16 $206

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$62,375

Medicare's payments for the services billed

Medicare patients

89

Average age 76

Services billed

175

31 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 74%
Heart failure 54%
Arthritis 52%
Atrial fibrillation 49%
Diabetes 45%
Chronic kidney disease 38%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $76
$76 — —
ABRYSVO
  • PFIZER INC. $5
$5 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

121 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record